Resonance Specialities Ltd (RESONANCE) — shareholding pattern, promoter holding, financials and share price
About Resonance Specialities Ltd (RESONANCE)
Resonance Specialities Ltd operates in the Specialty Chemicals industry, within the Chemicals sector. It trades on the NSE as RESONANCE and on the BSE under scrip code 524218. Its ISIN is INE486D01017.
Incorporated in 1989, Resonance Specialties Ltd manufactures Pyridine, Picoline, Cynopyridine and derivatives of the same [1]
Resonance Specialities Limited manufactures and markets Pyridine and Pyridine derivatives, Picoline, and Cyanopyridine, serving industries like pharmaceuticals, chemicals, and agro-chemicals.
The company's plant is strategically located in the Tarapur Industrial Zone, providing easy access to resources and distribution channels.
Listed peers in Specialty Chemicals: KKalpana Industries (India) Ltd, Vikas Ecotech Ltd, Cochin Minerals & Rutile Ltd, Jaysynth Orgochem Ltd, IVP Ltd, Ishan Dyes and chemicals Ltd.
Valuation & Returns
28 Jul 2026At ₹145.9 a share on 28 Jul 2026, Resonance Specialities Ltd (RESONANCE) was valued at a price-to-earnings ratio of 16.19x against an industry P/E of 44.66x and a price-to-book of 2.3x on a book value of ₹63.44 per share as of Mar 2026. Solomo computes return on equity of 14.2% and return on capital employed of 18.96% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 16.19x
- Industry P/E
- 44.66x
- P/B
- 2.3x
- EPS (TTM)
- ₹9.01
- Book value / share
- ₹63.44
- ROE
- 14.2%
- ROCE
- 18.96%
- ROA
- 11.25%
- Debt / equity
- 0.03x
- Dividend yield
- 1.37%
- EBITDA margin
- 17.34%
- 52-week range
- ₹77 – ₹150.65
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Resonance Specialities Ltd (RESONANCE) reported revenue of ₹90 crore, net profit of ₹10 crore and earnings per share of ₹9.01. That compares with revenue of ₹78 crore and net profit of ₹7 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹24.48 crore and net profit ₹4.6 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 76 | 58 | 55 | 78 | 90 |
| Net profit (₹ cr) | 12 | 5 | 3 | 7 | 10 |
| EPS (₹) | 10.71 | 4.33 | 2.57 | 5.69 | 9.01 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 10.40% | 3.00% | 11.08% | 15.99% |
| Profit growth | 29.34% | -0.25% | 27.62% | 58.30% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 54.25% of Resonance Specialities Ltd (RESONANCE) (unchanged from the previous quarter) and domestic institutional investors (DII) hold 1.55%. Market capitalisation was ₹168 crore on 28 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: Investor Education and Protection Fund 5.52%, SANGEETHA S 1.57%, 129 WEALTH FUND 1.52%, HUF 1.39%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 54.25% | - | - | 1.55% | 45.75% |
| Mar 2026 | 54.25% | - | - | 0.03% | 45.75% |
| Dec 2025 | 54.25% | - | - | 0.03% | 45.75% |
| Sep 2025 | 54.25% | - | - | 0.03% | 45.75% |
| Jun 2025 | 54.25% | - | - | 0.03% | 45.75% |
| Mar 2025 | 54.25% | - | - | 0.03% | 45.75% |
| Dec 2024 | 54.25% | - | - | 0.03% | 45.75% |
| Sep 2024 | 54.25% | - | - | 0.03% | 45.75% |